Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:22:42 EDT Sat 05 Oct 2024
Enter Symbol
or Name
USA
CA



Q:ANIP - ANI PHARMACEUTICALS INC - http://www.anipharmaceuticals.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ANIP - Q0.128.86·74.990.157.83+1.041.874.44,1442,41757.61  58.30  57.4470.81  48.3016:58:26Sep 2615 min RT 2¢

Recent Trades - Last 10 of 2417
Time ETExPriceChangeVolume
16:58:26Q57.831.04115
16:18:55Q59.072.281
16:02:11Q57.831.04163
16:02:02Q57.831.0469
16:01:40Q57.831.04413
16:01:17Q57.831.0431
16:00:08Q57.831.042,352
16:00:07Q57.831.0415
16:00:07Q57.831.0454
16:00:07Q57.831.0431

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-09-26 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
2024-09-16 08:53U:ANIPNews ReleaseANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
2024-09-16 06:50U:ANIPNews ReleaseANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
2024-09-13 06:50U:ANIPNews ReleaseANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
2024-09-11 06:50U:ANIPNews ReleaseANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
2024-09-10 14:10U:ANIPNews ReleaseANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
2024-08-13 16:05U:ANIPNews ReleaseANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes
2024-08-07 21:44U:ANIPNews ReleaseANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
2024-08-07 07:01U:ANIPNews ReleaseANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
2024-08-06 07:24U:ANIPSEDAR Interim MD & ASEDAR Interim MD & A
2024-08-06 07:19U:ANIPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-06 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
2024-07-31 07:00U:ANIPNews ReleaseANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET
2024-07-15 07:00U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
2024-07-02 07:00U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
2024-06-25 07:00U:ANIPNews ReleaseANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year(TM) 2024 New Jersey Award Winner
2024-06-24 06:51U:ANIPNews ReleaseANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
2024-05-29 16:30U:ANIPNews ReleaseANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
2024-05-21 13:59U:ANIPSEDAR Interim Financial StatementsSEDAR Interim MD & A